PRALUENT SOLUTION Canada - English - Health Canada

praluent solution

sanofi-aventis canada inc - alirocumab - solution - 75mg - alirocumab 75mg - proprotein convertase subtilisin kexin type 9 (pcsk9) inhibitors

PRALUENT SOLUTION Canada - English - Health Canada

praluent solution

sanofi-aventis canada inc - alirocumab - solution - 150mg - alirocumab 150mg - proprotein convertase subtilisin kexin type 9 (pcsk9) inhibitors

REPATHA SOLUTION Canada - English - Health Canada

repatha solution

amgen canada inc - evolocumab - solution - 120mg - evolocumab 120mg - proprotein convertase subtilisin kexin type 9 (pcsk9) inhibitors

IMCIVREE- setmelanotide solution United States - English - NLM (National Library of Medicine)

imcivree- setmelanotide solution

rhythm pharmaceuticals, inc - setmelanotide (unii: n7t15v1fuy) (setmelanotide - unii:n7t15v1fuy) - imcivree is indicated for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic or syndromic obesity due to: - pro-opiomelanocortin (pomc), proprotein convertase subtilisin/kexin type 1 (pcsk1), or leptin receptor (lepr) deficiency as determined by an fda-approved test demonstrating variants in pomc, pcsk1, or lepr genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (vus) [see dosage and administration (2.1) - bardet-biedl syndrome (bbs) [see dosage and administration (2.2)]. limitations of use: imcivree is not indicated for the treatment of patients with the following conditions as imcivree would not be expected to be effective: - obesity due to suspected pomc, pcsk1, or lepr deficiency with pomc , pcsk1 , or lepr variants classified as benign or likely benign - other types of obesity not related to pomc, pcsk1 or lepr deficiency or bbs, including obesity associated with other genetic syndromes and general (polygenic) obe

Articulating paper Australia - English - Department of Health (Therapeutic Goods Administration)

articulating paper

honour international trading pty ltd - 16181 - dental articulation paper - a strip or sheet of suitable material coated with pigment and used for marking areas of contact between opposite teeth, restorations or appliances

Compress, hot/cold pack, single use Australia - English - Department of Health (Therapeutic Goods Administration)

compress, hot/cold pack, single use

telmead pty ltd - 40555 - compress, hot/cold pack, single use - compress, hot/cold pack, single use[40555]. intended purpose: a single use hot/cold pack to apply on body parts to provide heat or cold therapy for relief of pain and swelling.

Specimen receptacle IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

specimen receptacle ivds

cng group international pty ltd - ct936 - specimen receptacle ivds - device consists of a nasopharyngeal specimen collection swab and a tube containing 3 ml of transport medium suitable for virus samples.

AMPRONOR 300MG® 300MG/G ORAL SOLID ORDINARY UNIT DOSE POWDERS Uganda - English - National Drug Authority

ampronor 300mg® 300mg/g oral solid ordinary unit dose powders

hebei kexing pharmaceutical co., ltd. - amprolium hydrochloride - oral solid ordinary unit dose powders - 300mg/g

D.COLINOR EXTRA (400MG + 800000 IU + 10MG)/G ORAL SOLID ORDINARY UNIT DOSE POWDERS Uganda - English - National Drug Authority

d.colinor extra (400mg + 800000 iu + 10mg)/g oral solid ordinary unit dose powders

hebei kexing pharmaceutical co., ltd. - doxycycline hydrochloride + colistin sulfate + ambroxol hydrochloride - oral solid ordinary unit dose powders - (400mg + 800000 iu + 10mg)/g

ERYCONOR® (600,000 IU + 200MG) PER G ORAL SOLID ORDINARY POWDERS Uganda - English - National Drug Authority

eryconor® (600,000 iu + 200mg) per g oral solid ordinary powders

hebei kexing pharmaceutical co., ltd. - colistin sulphate + erythromycin thiocyanate - oral solid ordinary powders - (600,000 iu + 200mg) per g